Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study

Autor: Jeong, Hyehyun, Kim, Bum Jun, Lee, Choong-kun, Park, Inkeun, Zang, Dae Young, Choi, Hye Jin, Lee, Sang Soo, Park, Do Hyun, Song, Tae Jun, Oh, Dongwook, Moon, Sung-Hoon, Kim, Kyu-pyo, Wainberg, Zev, Ryoo, Baek-Yeol, Yoo, Changhoon
Zdroj: In European Journal of Cancer September 2024 208
Databáze: ScienceDirect
Externí odkaz: